Fate Therapeutics (FATE) has issued an update.
Fate Therapeutics, Inc. has updated its indemnification agreements for directors and officers, enhancing legal protections and clarifying provisions around changes in control and legal expense coverage. The new agreement ensures directors and officers have more specific rights to counsel and defense expense advancement, irrespective of insurance coverage, and establishes an express presumption of their good faith actions. This move reinforces the company’s commitment to its leadership in the face of potential legal challenges.
For a thorough assessment of FATE stock, go to TipRanks’ Stock Analysis page.
